Listed

Sensient Technologies Corp: Form 10-Q for the period ended Mar 31, 2021

Filed with the SEC on May 4, 2021 and accepted by EDGAR at May 4, 2021, 14:17 ET.

Share

Management's discussion and analysis

As filed, 25,344 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements that reflect management’s current assumptions and estimates of future economic circumstances, industry conditions, Company performance, and financial results. Forward-looking statements include statements in the future tense, statements referring to any period after March 31, 2021, and statements including the terms “expect,” “believe,” “anticipate,” and other similar terms that express expectations as to future events or conditions. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for such forward-looking statements. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, and other factors that could cause actual events to differ materially from those expressed in the forward-looking statements. A variety of factors could cause the Company’s actual results and experience to differ materially from the anticipated results. These factors and assumptions include, among others, the impact and uncertainty created by the ongoing COVID-19 pandemic, including, but not limited to, its effects on our employees, facilities, customers, and suppliers, the availability and cost of raw materials and other supplies, the availability of logistics and transportation, governmental regulations and restrictions, and general economic conditions; the pace and nature of new product introductions by the Company and the Company’s customers; the Company’s ability to anticipate and respond to changing consumer preferences and changing technologies; the Company’s ability to successfully implement its growth strategies; the outcome of the Company’s various productivity-improvement and cost-reduction efforts, acquisition and divestiture activities, and operational improvement plan; the effectiveness of the Company’s past restructuring activities; changes in costs of raw materials, including energy; industry, regulatory, legal, and economic factors related to the Company’s domestic and international business; the effects of tariffs, trade barriers, and disputes; growth in markets for products in which the Company competes; industry and customer acceptance of price increases; actions by competitors; currency exchange rate fluctuations; and the matters discussed under Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. Except to the extent required by applicable law, the Company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized.

OVERVIEW

Revenue

Revenue was $359.7 million and $350.7 million for the three months ended March 31, 2021 and 2020, respectively. For the three months ended March 31, 2021, the impact of foreign exchange rates increased consolidated revenue by approximately 3%.

Gross Margin

The Company’s gross margin was 32.1% and 31.9% for the three months ended March 31, 2021 and 2020, respectively.

Selling and Administrative Expenses

Selling and administrative expense as a percent of revenue was 19.1% and 22.1% for the three months ended March 31, 2021 and 2020, respectively.

Selling and administrative expenses for the three months ended March 31, 2021 included divestiture & other related expenses and operational improvement plan costs totaling $2.5 million. For the three months ended March 31, 2020, selling and administrative expenses included divestiture & other related expense totaling $11.7 million. There were no operational improvement plan costs for the three months ended March 31, 2020. These expenses increased selling and administrative expense as a percent of revenue by 70 and 330 basis points for the three months ended March 31, 2021 and 2020, respectively.

Operating Income

Operating income was $46.9 million and $34.6 million for the three months ended March 31, 2021 and 2020, respectively. Operating margins were 13.0% and 9.9% for the three months ended March 31, 2021 and 2020, respectively. The increase in operating margin is primarily due to lower divestiture & other related costs and operational improvement plan costs, which decreased operating margins by 70 and 340 basis points for the three months ended March 31, 2021 and 2020, respectively, and an increase in margin at the Flavors & Extracts segment.

Interest Expense

Interest expense was $3.4 million and $4.3 million for the three months ended March 31, 2021 and 2020, respectively. The decrease in expense was due to the decrease in the average debt outstanding and lower average interest rates.

Income Taxes

The effective income tax rates for the three months ended March 31, 2021 and 2020, were 27.1% and 31.3%, respectively. The effective tax rates for the three months ended March 31, 2021 and 2020 were both impacted by changes in estimates associated with the finalization of prior year foreign tax items and the mix of foreign earnings.

Divestitures

In October 2019, the Company announced its intent to divest its inks, fragrances (excluding its essential oils product line), and yogurt fruit preparations product lines.

On June 30, 2020, the Company completed the sale of its inks product line. In 2020, the Company received $11.6 million of net cash and expects to receive additional cash when it completes certain post-closing asset sales.

On September 18, 2020, the Company completed the sale of its yogurt fruit preparations product line for $1.0 million. The sale included an earn-out based on future performance, which could result in additional cash consideration for the Company.

On April 1, 2021, the Company completed the sale of its fragrances product line (excluding its essential oils product line). The Company received $4.1 million as of March 31, 2021, in advance of the closing and received or expects to receive, an estimated additional $32 million of net cash in the second quarter of 2021, of which $4.7 million is subject to an escrow arrangement and will be released following the receipt of an affirmation or non-objection to our proposed environmental remediation plan by the Spanish environmental authorities. The proceeds are subject to post-closing working capital and net debt adjustments. In the second quarter of 2021, the Company estimates it will record a non-cash net loss of approximately $12 million primarily related to the reclassification of accumulated foreign currency translation and related items from Accumulated Other Comprehensive Loss to Selling and Administrative Expenses in the Consolidated Statements of Earnings as a result of the sale.

Operational Improvement Plan

During the third quarter of 2020, the Company approved an operational improvement plan (Operational Improvement Plan) to consolidate manufacturing facilities and improve efficiencies within the Company. As part of the Operational Improvement Plan, the Company is combining its New Jersey cosmetics manufacturing facility in the Personal Care product line of the Color segment into its existing Color segment facility in Missouri. In addition, the Company is centralizing certain Flavors & Extracts segment support functions in Europe into one location. In the Asia Pacific segment, the Company incurred costs in connection with the elimination of certain selling and administrative positions. The Company reports all costs associated with the Operational Improvement Plan in Corporate & Other.

In the three months ended March 31, 2021, the Company incurred $1.0 million related to the Operational Improvement Plan, primarily for costs associated with exiting its New Jersey cosmetics manufacturing facility.

COVID-19

COVID-19 has adversely affected, and is expected to continue to adversely affect, most of the world, including through widespread illness, quarantines, factory shutdowns, and travel and transportation disruptions. While the Company’s financial position remains strong, the Company has seen several financial and operational impacts from the pandemic as of this filing.

For the three months ended March 31, 2021, demand for many of the Company’s products remained strong, especially in product lines that serve the food, beverage, and pharmaceutical markets. There has been continued softer demand in other product lines the Company serves, particularly in the cosmetics product line and some product lines that supply the quick service restaurant segment due to continued widespread restaurant capacity and other operating restrictions. While COVID-19 appears to have initially contributed to demand for food-related products and dampened demand for personal care related products, it is difficult to quantify the continuing and future impact of COVID-19 on demand for the Company’s products.

During the first quarter of 2020, the Company had a production facility in China and a production facility in India that were required to temporarily suspend operations. In addition, during the fourth quarter of 2020, the Company had a production facility in China that was required to temporarily suspend operations. All of the Company’s production facilities are open and operating as of this filing, but the Company continues to monitor developments and regulations in regions where its production facilities are located. The Company also continues to monitor supply chains and has increased inventory in certain key raw materials. The Company did not experience any significant supply disruptions related to COVID-19 during the three months ended March 31, 2021.

As of March 31, 2021, the Company continues to be in compliance with its financial loan covenants and does not anticipate any non-compliance in the future. COVID-19 has not adversely impacted the Company’s capital or financial resources. Furthermore, the Company expects its forecasted cash flows from operations and its available debt capacity will be able to meet future cash requirements for operations, capital expenditures, contractual maturities on long-term debt, stock repurchases, and dividend payments.

The Company continues to monitor its trade accounts receivables for potential collection issues and has not identified any significant concerns as of this filing. The Company will continue to monitor cash collections and review trade receivable aging to identify any deterioration in quality.

For the three months ended March 31, 2021 and 2020, the Company estimates that the incremental expenses related to its COVID-19 response were approximately $0.7 million and $0.3 million, respectively. These incremental expenses are in addition to any profit impact related to lower sales in certain product lines where consumer demand has been negatively impacted by COVID-19.

The Company continues to believe its internal controls over financial reporting and its disclosure controls and procedures are effective to ensure their design and operation continue to be effective as some employees perform tasks from alternative work locations. Internal audit continues to perform their audit procedures, remotely in many cases, as planned.

Overall, governmental and social responses to the COVID-19 pandemic continue to evolve. In particular, there continues to be uncertainty related to the timing and extent of vaccination programs, especially outside of the U.S., as well as the impacts of new COVID-19 variants, and we expect that the situation will remain dynamic and difficult to predict for the foreseeable future. There can be no assurance that our experience to date with respect to facility operations, customer demand, the availability of supplies and transportation, and other factors impacting our results and financial condition will be predictive of the ongoing impacts in the short or long term. Even as stay-home orders and quarantines are eventually lifted, it is difficult to predict how economic conditions and changes in customer and consumer behavior may impact our results over the longer term. As a result of any of the foregoing, our results or financial condition could be adversely impacted and the impacts could be material.

NON-GAAP FINANCIAL MEASURES

Within the following tables, the Company reports certain non-GAAP financial measures, including: (1) adjusted revenue, adjusted operating income, adjusted net earnings, and adjusted diluted earnings per share, which exclude the results of the product lines divested or to be divested, the divestiture & other related costs, and the operational improvement plan costs, and (2) percentage changes in revenue, operating income, and diluted earnings per share on an adjusted local currency basis, which eliminate the effects that result from translating its international operations into U.S. dollars, the results of product lines divested or to be divested, the divestiture & other related costs or income, and the operational improvement plan costs.

The Company has included each of these non-GAAP measures in order to provide additional information regarding our underlying operating results and comparable year-over-year performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. These non-GAAP measures should not be considered in isolation. Rather, they should be considered together with GAAP measures and the rest of the information included in this report. Management internally reviews each of these non-GAAP measures to evaluate performance on a comparative period-to-period basis and to gain additional insight into underlying operating and performance trends, and the Company believes the information can be beneficial to investors for the same purposes. These non-GAAP measures may not be comparable to similarly titled measures used by other companies.

(In thousands except per share amounts)

Three Months Ended March 31, 2021 2020 % Change
Revenue (GAAP) $359,702 $350,677 2.6%
Revenue of the product lines divested or to be divested (25,570) (36,585)
Adjusted revenue $334,132 $314,092 6.4%
Operating Income (GAAP) $46,897 $34,561 35.7%
Divestiture & other related costs – Cost of products sold 25 190
Divestiture & other related costs – Selling and administrative expenses 1,547 11,653
Operating income of the product lines divested or to be divested (2,927) (1,385)
Operational improvement plan – Selling and administrative expenses 1,001 -
Adjusted operating income $46,543 $45,019 3.4%
Net Earnings (GAAP) $31,668 $20,773 52.4%
Divestiture & other related costs, before tax 1,572 11,843
Tax impact of divestiture & other related costs 793 (934)
Net earnings of the product lines divested or to be divested, before tax (2,927) (1,385)
Tax impact of the product lines divested or to be divested 723 297
Operational improvement plan costs, before tax 1,001 -
Tax impact of operational improvement plan (296) -
Adjusted net earnings $32,534 $30,594 6.3%
Diluted Earnings Per Share (GAAP) $0.75 $0.49 53.1%
Divestiture & other related costs, net of tax 0.06 0.26
Results of operations of the product lines divested or to be divested, net of tax (0.05) (0.03)
Operational improvement plan, net of tax 0.02 -
Adjusted diluted earnings per share $0.77 $0.72 6.9%

Divestiture & other related costs are discussed under “Divestitures” above and Note 2, Divestitures, in the Notes to the Consolidated Condensed Financial Statements included in this report. Operational improvement plan is discussed under “Operational Improvement Plan” above and Note 3, Operational Improvement Plan, in the Notes to the Consolidated Condensed Financial Statements included in this report.

Note: Earnings per share calculations may not foot due to rounding differences.

The following table summarizes the percentage change for the results of the three months ended March 31, 2021, compared to the results for the three months ended March 31, 2020, in the respective financial measures.

Revenue Three Months Ended March 31, 2021 Total Foreign Exchange Rates Adjustments (1) Adjusted Local Currency
Flavors & Extracts 7.7% 2.4% (3.6%) 8.9%
Color (5.4%) 2.4% (5.9%) (1.9%)
Asia Pacific 11.1% 5.9% 0.5% 4.7%
Total Revenue 2.6% 2.7% (4.1%) 4.0%
Operating Income
Flavors & Extracts 29.5% 1.9% 6.4% 21.2%
Color (10.3%) 3.3% (0.3%) (13.3%)
Asia Pacific 33.5% 1.3% 0.8% 31.4%
Corporate & Other (36.0%) 0.0% (54.5%) 18.5%
Total Operating Income 35.7% 4.1% 31.3% 0.3%
Diluted Earnings per Share 53.1% 4.1% 44.8% 4.2%

(1) For Revenue, adjustments consist of revenues of the product lines divested or to be divested. For Operating Income and Diluted Earnings per Share, adjustments consist of the results of the product lines divested or to be divested, divestitures & other related costs, and operational improvement plan costs.

Note: Refer to table above for a reconciliation of these non-GAAP measures.

SEGMENT INFORMATION

The Company determines its operating segments based on information utilized by its chief operating decision maker to allocate resources and assess performance. Segment performance is evaluated on operating income before any applicable divestiture & other related costs, share-based compensation, acquisition, restructuring including the operational improvement plan, and other costs (which are reported in Corporate & Other), interest expense, and income taxes.

The Company’s reportable segments consist of the Flavors & Extracts, Color, and Asia Pacific segments.

Flavors & Extracts

Flavors & Extracts segment revenue was $200.9 million and $186.5 million for the three months ended March 31, 2021 and 2020, respectively, an increase of approximately 8%. Foreign exchange rates increased segment revenue by approximately 2%. The increase was a result of higher revenue in Flavors, Extracts & Flavor Ingredients and Natural Ingredients, which was partially offset by lower revenue due to the divestiture of Yogurt Fruit Preparations in September of 2020. The higher revenue in Flavors, Extracts & Flavor Ingredients was primarily due to higher volumes and the favorable impact of exchange rates. The higher revenue in Natural Ingredients was primarily due to higher volumes and selling prices.

Flavors & Extracts segment operating income was $27.0 million and $20.9 million for the three months ended March 31, 2021 and 2020, respectively, an increase of approximately 30%. Foreign exchange rates increased segment operating income by approximately 2%. The higher segment operating income was primarily a result of higher volumes and lower manufacturing and other costs in Flavors, Extracts & Flavor Ingredients and lower manufacturing and other costs in Fragrances. Segment operating income as a percent of revenue was 13.4% in the current quarter compared to 11.2% in the prior year’s comparable quarter.

Color

Segment revenue for the Color segment was $135.7 million and $143.5 million for the three months ended March 31, 2021 and 2020, respectively. Foreign exchange rates increased segment revenue by approximately 2%. The decrease was a result of lower segment revenue in Personal Care and the divestiture of Inks, partially offset by higher revenue in Food & Pharmaceutical Colors. The lower revenue in Personal Care was due to lower volumes due to lower demand for makeup products primarily due to COVID-19. The divestiture of the Inks product line on June 30, 2020 also contributed to lower segment revenue. The higher revenue in Food & Pharmaceutical Colors was primarily due to higher volumes and the favorable impact of exchange rates.

Segment operating income for the Color segment was $26.6 million and $29.7 million for the three months ended March 31, 2021 and 2020, respectively. Foreign exchange rates increased segment operating income by approximately 3%. The decrease in segment operating income was a result of lower segment operating income in Personal Care and Food & Pharmaceutical Colors. The lower operating income in Personal Care was due to lower volumes as a result of lower demand for makeup products primarily due to COVID-19. The lower operating income in Food & Pharmaceutical Colors was due to unfavorable product mix. Segment operating income as a percent of revenue was 19.6% in the current quarter and 20.7% in the prior year’s comparable quarter.

Asia Pacific

Segment revenue for the Asia Pacific segment was $33.8 million and $30.4 million for the three months ended March 31, 2021 and 2020, respectively, an increase of approximately 11%. The increase was a result of the favorable impact of foreign exchange rates, which increased segment revenue by approximately 6%, and higher volumes.

Segment operating income for the Asia Pacific segment was $6.8 million and $5.1 million for the three months ended March 31, 2021 and 2020, respectively, an increase of approximately 34%. The increase was primarily a result of higher volumes. Foreign exchange rates increased segment operating income by approximately 1%. Segment operating income as a percent of revenue was 20.0% in the current quarter and 16.6% in the prior year’s comparable quarter.

Corporate & Other

The Corporate & Other operating expense was $13.5 million and $21.0 million for the three months ended March 31, 2021 and 2020, respectively. The lower operating expense for the three months ended March 31, 2021 was primarily due to lower divestiture & other related expenses of $1.6 million in the current period compared to $11.8 million in the prior year comparable period. These lower divestiture & other related expenses were partially offset by an increase in performance-based executive compensation and operational improvement costs in the current period. There were no operational improvement plan costs in the prior year’s comparable period.

LIQUIDITY AND FINANCIAL CONDITION

Financial Condition

The Company’s financial position remains strong. The Company is in compliance with its loan covenants calculated in accordance with applicable agreements as of March 31, 2021. The Company expects its cash flow from operations and its existing debt capacity can be used to meet anticipated future cash requirements for operations, capital expenditures, dividend payments, acquisitions, and stock repurchases. The impact of inflation on both the Company’s financial position and its results of operations has been minimal and is not expected to significantly affect 2021 results.

Cash Flows from Operating Activities

Net cash provided by operating activities was $29.0 million and $36.9 million for the three months ended March 31, 2021 and 2020, respectively. The decrease in net cash provided by operating activities was primarily due to an $11.2 million increase in cash used in working capital during the three months ended March 31, 2021, compared to the three months ended March 31, 2020.

Cash Flows from Investing Activities

Net cash used in investing activities was $9.8 million and $4.9 million during the three months ended March 31, 2021 and 2020, respectively. During the three months ended March 31, 2021, the Company received cash proceeds of $4.1 million related to the Company’s divestiture activities, while in the three months ended March 31, 2020, the Company received $4.6 million related to the redemption of miscellaneous investments. Capital expenditures were $14.2 million and $9.4 million during the three months ended March 31, 2021 and 2020, respectively.

Cash Flows from Financing Activities

Net cash used in financing activities was $15.9 million and $18.2 million for the three months ended March 31, 2021 and 2020, respectively. Net debt increased by $12.5 million and decreased by $1.4 million for the three months ended March 31, 2021 and 2020, respectively. For purposes of the cash flow statement, net changes in debt exclude the impact of foreign exchange rates. The Company repurchased shares of its common stock for $11.7 million during the three months ended March 31, 2021. There were no repurchases of shares of the Company’s common stock in the comparable prior year’s period. Dividends of $16.5 million were paid during both the three months ended March 31, 2021 and 2020. Dividends paid were $0.39 per share for both the three months ended March 31, 2021 and 2020.

CRITICAL ACCOUNTING POLICIES

There have been no material changes in the Company’s critical accounting policies during the quarter ended March 31, 2021. For additional information about critical accounting policies, refer to “Critical Accounting Policies” under Item 7 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.

Market risk

As filed, 271 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes in the Company’s exposure to market risk during the quarter ended March 31, 2021. For additional information about market risk, refer to Part II, Item 7A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.

Controls and procedures

As filed, 1,130 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures: The Company carried out an evaluation, under the supervision and with the participation of management, including the Company’s Chairman, President, and Chief Executive Officer and its Senior Vice President and Chief Financial Officer, of the effectiveness, as of the end of the period covered by this report, of the design and operation of the disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act. Based upon that evaluation, the Company’s Chairman, President, and Chief Executive Officer and its Senior Vice President and Chief Financial Officer have concluded that the disclosure controls and procedures were effective as of the end of the period covered by this report.

Changes in Internal Control over Financial Reporting: There have been no changes in the Company’s internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) during the quarter ended March 31, 2021, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Risk factors

As filed, 164 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There were no material changes to the risk factors previously disclosed in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-01-01 to 2021-03-31$359.7mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Selling, general and administrative3 months2021-01-01 to 2021-03-31$68.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2021-01-01 to 2021-03-31$46.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-01-01 to 2021-03-31$3.4mus-gaap:InterestExpense
Income tax3 months2021-01-01 to 2021-03-31$11.8mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-01-01 to 2021-03-31$31.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-01-01 to 2021-03-31$0.75us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-01-01 to 2021-03-31$0.75us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-01-01 to 2021-03-3142,389,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2021-01-01 to 2021-03-31$29.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2021-01-01 to 2021-03-31$14.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2021-01-01 to 2021-03-31$16.5mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases3 months2021-01-01 to 2021-03-31$11.7mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2021-03-31$28.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-03-31$737.2mus-gaap:AssetsCurrent
Total assetsAt period end2021-03-31$1.72bnus-gaap:Assets
Current liabilitiesAt period end2021-03-31$198.8mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2021-03-31$524.2mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2021-03-31$925.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001140361-21-015680. Last ingested by Listed: Nov 4, 2026, 17:12 ET. Listed shows no prices and gives no investment advice.